Why the study?
Severe chronic AR with a giant LV carries a high risk of incomplete LV reverse remodeling after AVR, yet reliable preoperative stratification tools remain limited.
Is preoperative cardiac magnetic resonance-derived extracellular volume fraction (ECV) associated with 6-month left ventricular reverse remodeling after elective aortic valve replacement in patients with severe chronic aortic regurgitation and a giant left ventricle (LVEDD ≥65 mm)?
Cohort (n=46)
Blinded outcome assessment (radiologists and echocardiographers blinded to clinical outcomes)
No
Is preoperative cardiac magnetic resonance-derived extracellular volume fraction (ECV) associated with 6-month left ventricular reverse remodeling after elective aortic valve replacement in patients with severe chronic aortic regurgitation and a giant left ventricle (LVEDD ≥65 mm)?
Preoperative CMR-derived extracellular volume fraction is inversely associated with 6-month LV reverse remodeling after aortic valve replacement in patients with severe aortic regurgitation and a giant left ventricle, offering a potential non-invasive biomarker for preoperative risk stratification.
Answers are grounded in this paper and cite their sources.
ECV may aid preoperative risk stratification in severe AR with giant LV; leaves open whether it guides AVR timing or improves outcomes.
Severe chronic aortic regurgitation (AR) with a markedly dilated left ventricle (LV) (‘giant left ventricle’; LV end-diastolic diameter, LVEDD ≥65 mm) carries a high risk of incomplete LV reverse remodeling after aortic valve replacement (AVR), yet reliable preoperative stratification tools remain limited. This retrospective cohort study aimed to evaluate whether preoperative cardiac magnetic resonance (CMR)-derived extracellular volume fraction (ECV) is associated with 6-month LV reverse remodeling in this high-risk population. We enrolled 46 consecutive patients with severe AR and LVEDD ≥65 mm receiving contrast-enhanced CMR and elective AVR. The primary analysis assessed the association between preoperative ECV and the continuous relative change in LVEDD at 6 months; a binary definition (≥20% LVEDD reduction) was used as a secondary, clinically oriented outcome. Absence of significant LV reverse remodeling (<20% reduction) was observed in 47.8% (22/46) of patients. In linear regression analysis, higher preoperative ECV was significantly associated with a smaller LVEDD reduction ( β = −0.924 per 1% absolute increase in ECV, 95% CI −1.528 to −0.320, P = 0.004). In multivariable logistic regression restricted to the preoperative variables significant on univariable analysis (ECV and LVEDD), ECV remained associated with failed reverse remodeling (adjusted OR = 1.281 per 1% absolute increase in ECV, 95% CI 1.001–1.640, P = 0.049), although the association attenuated after further adjustment for age (OR 1.227, 95% CI 0.950–1.585, P = 0.117); with an exploratory cutoff of 34.1% (AUC=0.74, 95%CI 0.59–0.89). Patients with ECV >34.1% exhibited impaired postoperative LV systolic function and prolonged hospital stay. These exploratory findings suggest that preoperative CMR-ECV may help identify severe AR patients at risk of incomplete LV reverse remodeling after AVR, and warrant prospective validation.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2026) conducted a cohort in Severe chronic aortic regurgitation with a giant left ventricle (LVEDD ≥65 mm) undergoing elective aortic valve replacement (n=46). Preoperative CMR-derived extracellular volume fraction (ECV, per 1% absolute increase) vs. Lower preoperative ECV / ECV ≤34.1% was evaluated on Continuous relative change in left ventricular end-diastolic diameter (ΔLVEDD%) at 6 months after aortic valve replacement (β -0.924 per 1% absolute increase in ECV, 95% CI -1.528 to -0.320, p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: